4D Molecular Therapeutics Inc (FDMT)
25.31
-0.33
(-1.29%)
USD |
NASDAQ |
May 17, 16:00
25.31
0.00 (0.00%)
After-Hours: 20:00
4D Molecular Therapeutics Free Cash Flow: -79.44M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -79.44M |
| December 31, 2023 | -78.56M |
| September 30, 2023 | -76.67M |
| June 30, 2023 | -98.08M |
| March 31, 2023 | -97.18M |
| December 31, 2022 | -98.22M |
| September 30, 2022 | -101.85M |
| Date | Value |
|---|---|
| June 30, 2022 | -97.22M |
| March 31, 2022 | -92.19M |
| December 31, 2021 | -78.24M |
| September 30, 2021 | -69.32M |
| June 30, 2021 | -63.98M |
| March 31, 2021 | -53.33M |
| December 31, 2020 | -51.91M |
Free Cash Flow Range, Past 5 Years
-101.85M
Minimum
Sep 2022
-51.91M
Maximum
Dec 2020
-81.16M
Average
-79.00M
Median
Free Cash Flow Benchmarks
| Ionis Pharmaceuticals Inc | -345.48M |
| NovaBay Pharmaceuticals Inc | -4.524M |
| Palatin Technologies Inc | -33.83M |
| iBio Inc | -18.89M |
| Theriva Biologics Inc | -18.27M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -29.09M |
| Cash from Investing (Quarterly) | -263.26M |
| Cash from Financing (Quarterly) | 318.83M |
| Free Cash Flow Per Share (Quarterly) | -0.6048 |
| Free Cash Flow to Equity (Quarterly) | -29.80M |
| Free Cash Flow Yield | -7.26% |